Heartland Media Acquisition Corp.

We intend to focus on the media, entertainment and sports sectors. Our management team and Board of Directors (our “Board”) has had significant success sourcing, acquiring, growing and monetizing companies across these sectors. We have particular expertise in television broadcasting, and in local media generally. We believe this experience makes us well suited to identify, source, […]

December 13, 2021 Read More

Alpha Star Acquisition Corp.

We intend to focus on businesses with a connection to the Asian market. We will primarily seek to acquire one or more growth businesses with a total enterprise value of between $300 million and $600 million. Our focus will include these sectors: clean energy, the Internet and high technology, financial technology (FinTech), health care, consumer and […]

Read More

Power & Digital Infrastructure Acquisition II Corp.

We intend to initially focus our search on identifying a prospective target business in North America within the renewable and transition energy sector, with a focus on pursuing growth opportunities that are driving the electrical power grid transition, both on the electrical supply and on the demand side for high-intensity electrical users, as well as seeking […]

December 10, 2021 Read More

Trajectory Alpha Acquisition Corp.

Our objective is to identify and work with a disruptive, technology-driven business that leverages its unique intellectual property (“IP”) and proprietary data to develop a sustainable competitive advantage and, in turn, dislodge slower moving incumbents in the target’s selected end markets. Significant advances in software development, broadening of artificial intelligence applications, massive digitization of data […]

December 9, 2021 Read More

Southport Acquisition Corp.

We intend to focus on the financial software space with particular focus on mortgage and real estate verticals in the United States. Jeb Spencer is our Chief Executive Officer and a member of our board of directors. He is the co-founder and managing partner of TVC Capital, a software focused, growth equity fund, a position […]

Read More

Athena Technology Acquisition Corp. II

We expect to focus on a target in an industry where we believe the expertise of our management team and advisors will provide us with a competitive advantage. Our expertise lends itself well to pursuing companies operating in the FinTech, enterprise, deep tech and health-tech sectors. We also intend to look for businesses that create, produce, […]

Read More

THE GROWTH FOR GOOD ACQUISITION CORP.

The Growth for Good Acquisition Corp. is a new and differentiated blank check company focused on sponsoring the public listing of an inclusive and environmentally sustainable company with strong business fundamentals and high growth potential. A significant, although not sole, focus for us are “climate tech companies.” (Incorporated in the Cayman Islands)  The growth potential for […]

Read More

Healthcare AI Acquisition Corp.

We were founded by Stanley Capital, an independent investment firm focused on the growing sustainable investment sectors of healthcare, technology and resource efficiency. We intend to capitalize on the multiple decades of combined investment experience of our management and board of directors to identify and acquire a business that we believe provides opportunities for attractive risk-adjusted […]

Read More

BurTech Acquisition Corp.

We intend to focus our search on the retail, lifestyle, hospitality, technology or real estate markets. (Incorporated in Delaware) Our management team is led by Shahal Khan, our chairman and CEO; Isaac Chetrit, our president; Roman Livson, our CFO; Payel Farasat, our CIO, and Christopher Schroeder, our chief marketing officer. Shahal M. Khan is our chairman […]

Read More

Forbion European Acquisition Corp.

Our primary focus will be on the life sciences industry, which we believe represents a growing target market with a large number of potential target acquisition opportunities. With more than 5,000 diseases in need of effective treatment, and approximately 150 novel chemical entities approved in 2020 of which 97 were approved by the European Medicines […]

December 8, 2021 Read More
Page 105 of 283« First...102030...103104105106107...110120130...Last »